Topics
Glioblastoma | Treatment | Clinical trials | Fractionated
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Fractionated
Lin T, Ke S, Hu C, Assadi R, Huang J, Gupta S, Rawojc K, Kleinberg
L, Mukherjee D, Rincon-Torroella J, Weingart JD, Holdoff M,
Grossman S, Ahmed MM, Redmond KJ.
Low
Dose Fractionated Radiation Therapy As a Chemo-Potentiator of
Temozolomide for Recurrent Anaplastic Astrocytoma and
Glioblastoma: A Single-Arm Phase I/II Trial.
Int
J Radiat Oncol Biol Phys. 2025 Oct
24:S0360-3016(25)06396-5. doi:
10.1016/j.ijrobp.2025.10.014. PMID:
41138784. Interventional
study˰ ˍ
Di Muzio N, Torrisi M, Barzaghi R, Pocaterra A, Mori M, Folchini
F, Giannini L, Valle M, Bailo M, Deantoni CL, Snider S, Gagliardi
F, Ruggiero E, Broggi S, Ruffino L, Di Franco R, Mercogliano S,
Fiorino C, Del Vecchio A, Muto M, Muto P, Mortini P, Mondino A,
Fodor A.
Neoadjuvant
ultrahypofractionated radiotherapy with simultaneous integrated
boost for glioblastoma: study protocol for a phase I multicenter
clinical trial.
BMC
Cancer. 2026 Apr 6;26(1):633. doi:
10.1186/s12885-026-15950-2. PMID:
41942944. Trial
registration ID: NCT06551909. ˍ
de Jong AM, van der Boog ATJ, Wester G, Eekers DBP, Budiharto TCG,
Rozema T, Lagerwaard FJ, Bruynzeel AME, de Groot C, van der Meulen
M, Cialdella F, Dankbaar JW, Hendrikse J, Kleynen KE, Claes A,
Philippens MEP, Smid EJ, de Vos FYFL, van Rossum PSN, Robe PA,
David S, Snijders TJ, Verhoeff JJC.
Ultra-hypofractionated
versus conventional chemoradiation for newly diagnosed
glioblastoma: Survival and toxicity results of a multicenter
randomized trial.
Radiother
Oncol. 2026 Aug 8;223:111726. doi:
10.1016/j.radonc.2026.111726. PMID:
42570798. Trial
registration ID: NL72953.041.20.
ˍ